17th IBD Intensive Advanced Course

17th IBD Intensive Advanced Course
Date
March 6-7, 2019
Time 
Wednesday, March 6 from 08:00 to 16:45
Thursday, March 7 from 07:30 to 12:00
Organisation
EduCom
Target audience 
Junior gastroenterologists
Registration
Upon invitation only
ECCO Membership
Regular/Y-ECCO Membership 2019
Registration fee
N/A
Kindly direct any question or further clarification to the ECCO Office at This email address is being protected from spambots. You need JavaScript enabled to view it. 

  • 17th IBD Intensive Advanced Course
    (As of June 2018)
    08:00-08:15 Arrival and distribution of voting pads
    08:15–08:30 1: Welcome 
    Silvio Danese, Milan, Italy
    James Lindsay, London, United Kingdom

    08:30–09:15 Session 1: Pathogenesis
    Yehuda Chowers, Haifa, Israel
    08:30-08:45 2: Exposome
    Jonas Halfvarson, Örebrö, Sweden 
    08:45-09:00 3: Genetics
    Siew Ng, Hong Kong, China
    09:00-09:15 4: Inflammatory pathways
    Jesús Rivera-Nieves, San Diego, United States
    09:15-09:35 Coffee break
    09:35-11:20 Session 2: Part I: Case-based management of IBD therapies
    Axel Dignass, Frankfurt, Germany
    09:35-10:05 5: 5-ASA compounds
    Gerhard Rogler, Zurich, Switzerland
    10:05-10:20 6: Thiopurines
    Peter Irving, London, United Kingdom 
      10:20-10:35 7: Methotrexate
    Pascal Juillerat, Bern, Switzerland
      10:35-10:50 8: Steroids
    Fernando Gomollón Garcia, Zaragoza, Spain
      10:50-11:05 9: Anti-TNF agents
    Filip Baert, Roeselare, Belgium
    11:05-11:20 10: Anti-integrines
    James Lindsay, London, United Kingdom 
    11:20-12:05 Session 2: Part II: New biologics and small molecules
    Peter Irving, London, United Kingdom 
    11:20-11:35 11: Ustekinumab
    Marc Ferrante, Leuven, Belgium 
      11:35-11:50 12: Tofacitinib
    Florian Rieder, Cleveland, USA
      11:50-12:05 13: Other small molecules (aprimelast/ozanimod)
    Laurent Peyrin-Biroulet, Vandoeuvre-les-Nancy, France 
    12:05–13:25 Lunch break
    12:20-13:20 IBD Advanced Course Lunch Satellite Symposium Slot 1 TBC
    13:25-14:55 Session 3: Seminars: Part I: Special clinical situations
    13:25-14:10 EITHER:
    14a: Managing IBD and pregnancy
    Janneke van der Woude, Rotterdam, The Netherlands
    Iris Dotan, Petah Tikva, Israel
    OR:
    14b: Managing extraintestinal manifestations of IBD
    Stephan Vavricka, Zurich, Switzerland
    Peter Lakatos, Budapest, Hungary; Montreal, Canada

    14:10-14:55 EITHER:
    14a: Managing IBD and pregnancy
    Janneke van der Woude, Rotterdam, The Netherlands
    Iris Dotan, Petah Tikva, Israel

    OR:
    14b: Managing extraintestinal manifestations of IBD
    Stephan Vavricka, Zurich, Switzerland
    Peter Lakatos, Budapest, Hungary; Montreal, Canada

    14:55–15:15  Coffee break
    15:15–16:45 Session 3: Seminars. Part II: Long term management
    15:15-16:00 EITHER:
    15a: Managing complications associated with anti-TNF therapy
    Joana Torres, Lisbon, Portugal
    Shomron Ben-Horin, Ramat Gan, Israel

    OR: 
    15b: Endoscopy and IBD incl. chromo-endoscopy, balloon dilatation
    Pierre Michetti, Lausanne, Switzerland
    Henit Yanai, Petah Tikva, Israel 

     16:00-16:45 EITHER:
    15a: Managing complications associated with anti-TNF therapy
    Joana Torres, Lisbon, Portugal
    Shomron Ben-Horin, Ramat Gan, Israel

    OR: 
    15b: Endoscopy and IBD incl. chromo-endoscopy, balloon dilatation

    Pierre Michetti, Lausanne, Switzerland
    Henit Yanai, Petah Tikva, Israel 
  • 17th IBD Intensive Advanced Course
    (As of June 2018)
    07:30-09:30 Session 4: Interactive case discussions
    Pascal Juillerat, Bern, Switzerland
    Antonio López-Sanromán, Madrid, Spain
    07:30-08:00 16: Investigation and management of early Mild/Moderate Crohn's Disease
    Case presentation: Tim Raine, Cambridge, United Kingdom
    Discussion: Larry Egan, Galway, Ireland
    08:00-08:05 Discussion 
    08:05–08:40 17: Management of perianal CD
    Antonio López-Sanromán, Madrid, Spain
    Paulo Kotze, Curitiba, Brazil
    08:40-08:45 Discussion/Questions
      08:45-09:30 18. Optimal management of patient with Severe Crohn's Disease treated with anti-TNF agents
    Case presentation: Dominik Bettenworth, Münster, Germany
    Discussion: Pascal Juillerat, Bern, Switzerland
    Paulo Kotze, Curitiba, Brazil
    09:30-09:45 Coffee break
    09:45-11:50 Session 5: Special case scenarios
    Gerassimos Mantzaris, Athens, Greece 
    09:45–10:15 19: Medical management of Acute Severe Ulcerative Colitis
    David Laharie, Bordeaux, France 
      10:15-10:45 20: Pre- and postoperative management of Crohn's Disease
    Glen Doherty, Dublin, Ireland
    10:45-11:15 21: Management of refractory pouchitis
    Iris Dotan, Petah Tikva, Israel
    11:15-11:50 Discussion/Q&A Session
    11:50-12:00 22: Feedback & Closing remarks
    Pascal Juillerat, Bern, Switzerland